The number of intratumoral dendritic cells and ζ-chain expression in T cells as prognostic and survival biomarkers in patients with oral carcinoma

Cancer

Volumn 91, Issue 11, 2001, Pages 2136-2147

  Reichert, Torsten E ^a   Scheuer, Claudia ^a   Day, Roger ^b,c   Wagner, Wilfried ^a   Whiteside, Theresa L ^b,d  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^c UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

chain; Biomarkers; Dendritic cells; Oral carcinoma; Survival; T lymphocytes

Indexed keywords

PROTEIN P55; PROTEIN S 100; T LYMPHOCYTE RECEPTOR;

ADULT; AGED; ANTIGEN PRESENTING CELL; ARTICLE; CANCER GRADING; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CELL COUNT; DENDRITIC CELL; DISEASE MARKER; FEMALE; HUMAN; HUMAN TISSUE; LYMPHOCYTIC INFILTRATION; MAJOR CLINICAL STUDY; MALE; MOUTH CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; SQUAMOUS CELL CARCINOMA; T LYMPHOCYTE;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; DENDRITIC CELLS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RECEPTORS, ANTIGEN, T-CELL; S100 PROTEINS; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 0035370880     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0142(20010601)91:11<2136::AID-CNCR1242>3.0.CO;2-Q     Document Type: Article

References (25)

1. Banchereau J, Steinman R. Dendritic cells and the control of immunity. Nature 1998;392:245-52.
2. Banchereau J, Briere F, Caux C, DaVoust J, Lebecque S, Liu Y-J, et al. Immunobiology of dendritic cells. Annu Rev Immunol 2000;18:767-811.
3. Bell D, Young JW, Banchereau J. Dendritic cells. Adv Immunol 1999;72:255-324.
4. Mayordomo JI, Zorina T, Storkus WJ, Celluzzi C, Falo LD, Melief CJ, et al. Bone marrow-derived dendritic cells pulsed with tumor peptides effectively treat established murine tumors. Nature Med 1995;1:1297-302.
5. Falo LD Jr., Kovacsovics-Bankowski M, Thompson K, Rock KL. Targeting antigen into the phagocytic pathway in vivo induces protective tumor immunity. Nature Med 1995:1: 649-53.
6. Cella M, Salustzo F, Lanzavecchia A. Origin, maturation and antigen-presenting function of dendritic cells. Curr Opin Immunol 1997;9:10-6.
7. Almand B, Ressa JR, Lindman B, Nadaf S, Clark JI, Kwon ED, et al. Clinical significance of defective dendritic cell differentiation in cancer. Clin Cancer Res 2000;6:1755-66.
8. Becker Y. Dendritic cell activity against primary tumors: an overview. In Vivo 1993;7:187-91.
9. Zeid NA, Muller HK. S- 100-positive dendritic cells in human lung tumors associated with cell differentiation and enhanced survival. Pathology 1993;25:338-43.
10. Furihata M, Ohtsuki Y, Ido E, Iwata J, Sonobe H, Araki K, et al. HLA-DR antigen- and S-100 protein-positive dendritic cells in esophageal squamous cell carcinoma - their distribution in relation to prognosis. Virchows Arch B 1992;61: 409-14.
11. Tsujitani S, Tsugio F, Tumada R, Okamura T, Yasumoto K, Sugimachi K. Langerhans cells and prognosis in patients with gastric carcinoma. Cancer 1987;59:501-5.
12. Giannini A, Bianchi S, Messerini L, Gallo O, Gallina E, Libonati GA, et al. Prognostic significance of accessory cells and lymphocytes in nasopharyngeal carcinoma. Pathol Res Pract 1991;187:496-502.
13. Gallo O, Libonati GA, Gallina E, Fini-Storchi O, Giannini A, Urso C, et al. Langerhans cells related to prognosis in patients with laryngeal carcinoma. Arch Otolaryngol Head Neck Surg 1991;117:1007-10.
14. Goldman SA, Baker E, Weyant RJ, Clarke MR, Myers JN, Lotze MT. Peritumoral CD1a-positive dendritic cells are associated with improved survival in patients with tongue carcinoma. Arch Otolaryngol Head Neck Surg 1998;124:641-6.
15. Tsujitani S, Kakeji Y, Watanbe A, Kohnoe S, Maehara Y, Sugimachi K. Infiltration of dendritic cells in relationship to tumor invasion and lymph node metastasis in human gastric cancer. Cancer 1990;66:2012-6.
16. Murphy GF, Radu A, Kaminer M, Berd D. Autologous melanoma vaccine induces inflammatory response in melanoma metastases: relevance to immunologic regression and immunotherapy. J Invest Dermatol 1993;100:335S.
17. Albert ML, Sauter B, Bhardwaj N. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature 1998;392:86-9.
18. Hoffmann TKH, Meidenbauer N, Dworacki G, Kanaya H, Whiteside TL. Generation of tumor-specific T lymphocytes by cross-priming with human dendritic cells ingesting apoptotic tumor cells. Cancer Res 2000;60:3542-9.
19. Reichert TE, Day R, Wagner EM, Whiteside TL. Absent of low expression of the ζ chain in T cells at the tumor site correlates with poor survival in patients with oral carcinoma. Cancer Res 1998;58:5344-7.
20. Mosialos G, Birkenbach M, Ayehunie S, Matsumura F, Pinkus GS, Kieff E, et al. Circulating human dendritic cells differentially express high levels of a 55 kd actin-bundling protein. Am J Pathol 1996;148:593-600.
21. Sonderbye L, Magerstadt R, Blatman RN, Preffer FJ, Langhoff E. Selective expression of human fascin (p55) by dendritic leukocytes. Adv Exp Med Biol 1997;417:41-6.
22. Battifora H. Assessment of antigen damage in immunocytochemistry. The vimentin internal control. Am J Pathol 1991;96:669-71.
23. Brieman L, Friedman JH, Oshen RA, Stone CJ. Classification and regression trees. London: Wadsworth International Group, 1984.
24. Winek RR, Scheithauer BW, Wick MR. Meningioma, meningeal hemangiopericytoma (angioblastic meningioma), peripheral hemangiopericytoma, and acoustic Schwannoma. A comparative immunohistochemical study. Am J Surg Pathol 1989;13(4):251-61.
25. Malliard RB, Lotze MT. Dendritic cells prolong tumor-specific T cell survival and effector function following interaction with tumor targets. Clin Cancer Res (in press).